Skip to main content
Clinical Trials/JPRN-jRCT1051220039
JPRN-jRCT1051220039
Recruiting
未知

Efficacy and safety of aspirin in patients with chronic coronary syndromes without revascularization - ASA-IN study

Yamamoto Erika0 sites2,890 target enrollmentJune 9, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Yamamoto Erika
Enrollment
2890
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 9, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Yamamoto Erika

Eligibility Criteria

Inclusion Criteria

  • Patients with chronic coronary syndromes who have more than 50 percent diameter stenosis in one or more major coronary vessels/major branches, but are not eligible for revascularization

Exclusion Criteria

  • History of ACS
  • History of PCI or CABG
  • Patients with left main trunk stenosis
  • Patients for whom aspirin administration is mandatory
  • Patients undergoing antithrombotic therapy other than aspirin
  • History of stroke within 6 months
  • Patients scheduled for major surgical procedures that will require aspirin discontinuation
  • Patients with contraindication of aspirin
  • Patients expected to have a prognosis of 1 year or less due to comorbidities
  • Women of child\-bearing potential or women who have a positive pregnancy test at enrollment or randomization

Outcomes

Primary Outcomes

Not specified

Similar Trials